When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
The Promise of Cannabis as We Age
Biohacking...or BS?
Justine Bateman on Why She Won’t Try To Look Younger
The Myth of the Midlife Crisis
A Little Help From My Friends
Chasing Life presents The Prince Mixtape
Making the Most of the Bodies We Have
Is Age Really Just a Number?
Season Seven: Making the Most of Your Age
Inside the Surgeon General’s Dire Social Media Warning
Sanjay Investigates “The CBD Craze” Pt. 2
Sanjay Investigates “The CBD Craze” Pt. 1
Sanjay investigates "Weed" Pt. 2
Sanjay investigates "Weed" Pt. 1
Chasing Life presents The Assignment with Audie Cornish
The Guptas on Parenting in the Social Media Era
Inside a Lab Studying Toddlers and Touchscreens
Will Banning TikTok Help Kids?
The Selfie Effect on Your Brain
Hank Green on the Future of the Internet
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Up First